Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» diabetes
diabetes
Diabetes rivalries get more complicated with new FDA warning on J&J's Invokana
Fierce Pharma Marketing
Mon, 09/14/15 - 11:01 am
diabetes
FDA
Invokana
JNJ
Jardiance
Boehringer Ingelheim
Eli Lilly
MannKind: Failure to Launch
Barron's
Wed, 09/9/15 - 09:57 pm
MannKind
Afrezza
diabetes
Sanofi
inhaled insulin
Diabetes: LabStyle Innovations raises $2.3m for Dario device
Mass Device
Wed, 09/9/15 - 10:41 am
diabetes
devices
Labstyle Innovations
Dario
mobile apps
Zafgen Completes Enrollment of Phase 2b Trial of Beloranib in Severe Obesity Complicated by Type 2 Diabetes
Yahoo
Wed, 09/9/15 - 08:05 am
Zafgen
beloranib
clinical trials
obesity
diabetes
Novartis CEO says diabetics' contact lens tests to start in 2016 -paper
Yahoo/Reuters
Sat, 09/5/15 - 11:13 am
Novartis
Joe Jimenez
diabetes
contact lens
Google
Jardiance and its CV data? They're no knockout punch for stalwart Januvia, Merck says
Fierce Pharma
Wed, 09/2/15 - 10:27 am
Jardiance
diabetes
Eli Lilly
Boehringer Ingelheim
Merck
Januvia
Amgen Finds Data Falsified in Obesity-Diabetes Study Featuring Grizzly Bears
WSJ Online
Tue, 09/1/15 - 06:34 pm
Amgen
diabetes
obesity
Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes
Yahoo
Mon, 08/31/15 - 09:43 am
Sanofi
diabetes
R&D
Google
'No signal' of heart failure risk with Merck's Januvia, analysis confirms
Fierce Pharma
Mon, 08/31/15 - 11:13 am
Merck
Januvia
hear failure
diabetes
Lilly, Boehringer amp up fight against Lantus with U.K. biosim launch
Fierce Pharma
Sat, 08/29/15 - 08:57 am
Lantus
Eli Lilly
biosimilars
diabetes
Boehringer Ingelheim
Sanofi
FDA warns of severe joint pain risk with DPP-4 diabetes drugs
Yahoo/Reuters
Fri, 08/28/15 - 05:52 pm
FDA
diabetes
joint pain
DPP-4 inhibitor
Merck
Januvia
Onglyza
AstraZeneca
Takeda
Boehringer Ingelheim
Intarcia vs. Novo: Which has the most appealing diabetes PhIII program?
Fierce Pharma
Fri, 08/28/15 - 05:44 pm
Novo Nordisk
Intarcia
diabetes
ITCA-650
Merck
Januvia
semaglutide
Novo Nordisk buys diabetes startups founded by Lilly R&D veteran
Fierce Biotech
Fri, 08/28/15 - 09:51 am
Novo Nordisk
M&A
Eli Lilly
R&D
diabetes
Calibrium
MB2
Eli Lilly's Diabetes Drug May Halt Heart Disease
Motley Fool
Fri, 08/28/15 - 08:18 am
Eli Lilly
Jardiance
stroke
diabetes
Boehringer Ingelheim
Novo jumping into phase III trials for major oral diabetes candidate
BioPharma Dive
Thu, 08/27/15 - 11:36 am
Novo Nordisk
diabetes
semaglutide
GLP-1 agonist
MannKind And Afrezza: Can The Drug Cure The Company?
Forbes
Wed, 08/26/15 - 08:41 pm
MannKind
Afrezza
diabetes
inhaled insulin
Novo pulls blockbuster diabetes med Victoza off the Type 1 track
Fierce Pharma Marketing
Wed, 08/26/15 - 10:41 am
Novo Nordisk
Victoza
diabetes
type 1 diabetes
3 Reasons Why Afrezza's Launch Has Been So Disappointing
Motley Fool
Tue, 08/25/15 - 01:13 pm
Afrezza
MannKind
inhaled insulin
diabetes
Sanofi
insulin
Marijuana Gains Traction In Fight Against Diabetes And Obesity
Yahoo/Benzinga
Tue, 08/25/15 - 08:19 am
Medical Marijuana
obesity
diabetes
GW Pharma
Google Reveals Gigantic Ambitions To Fight Cancer, Diabetes, Parkinson's, Heart Problems
Forbes
Mon, 08/24/15 - 05:16 pm
Google
Alphabet
diabetes
Parkinson's Disease
cancer
heart disease
Pages
« first
‹ previous
…
47
48
49
50
51
52
53
54
55
…
next ›
last »